farmasierra

SECTOR: Health, Pharmaceuticals and Biotechnology

BrazilUgandato CanadaAsiaLatin AmericaJapanAfricaEuropeChinaUnited StatesKenya

Date	Operation Summary	Key Figures / Investment	Destination Country
2023-04-25	Farmasierra exceeded its financial expectations in 2022 thanks to the recovery of its international business, expanding its FDA certification to manufacture and ship new pharmaceutical formulations to the United States. It forecasts 10% growth in 2023 and 5% in 2024. Read News	Growth of 10% in 2023 and 5% in 2024. Investments of 2,2 million euros in 2023 and 1,6 million euros in 2024. Production increase of 15%.	United States
2023-03-30	Farmasierra has strengthened its international operations, exporting a new product to the US and establishing new routes to Japan and China. It is also finalizing a new license for Brazil, bringing products manufactured in Spain to more than 60 countries across five continents. Read News	It exports to more than 60 countries. Production capacity of more than 70 million units.	United States, Canada, Latin America, Africa, Asia, Japan, China, Brazil, Kenya, Uganda, Europe